Flanders has showcased as a region with great potential in the pharmaceutical market. The region is characterised by exceptionally rapid approval times for clinical trials and puts heavy emphasis on biotech R&D, through a well-developed ecosystem of startups, SMEs and larger international companies. Different strategic research centra (VIB, imec, VITO) focus on aspects related to personalised medicine and work on the valorisation of their research.
Personalised medicine is furthermore one of the priorities in Flanders' smart specialisation strategy. In this light, Flanders is one of the leading regions in the smart specialisation partnership on personalised medicine (S3P4PM) and coordinator of the SAPHIRe project.
Policy document (RIS3): Yes
Policy document PM@RIS3: Yes
Vlaamse Beleidsplan Gepersonaliseerde Geneeskunde
Vlaanderen in transitie
press release: SAPHIRe
National action plan eHealth
GAP (Genomics Application Platform)
VIB Grand Challenges program
Elixir Belgium Data
Centers for Medical Genetics Genome sequencing infrastructure
VIB strategic research centra
imec strategic research centra
VITO strategic research centra
Wetenschapspark UAntwerpen in Niel
EIT Health Benelux
Is the region represented in: Horizon2020; Regional Smart Specialisation Strategy Platforms/Partnerships (RIS3); EIT Health/InnoStars/Regional Innovation Scheme (RIS); other?
If you would like to add your region to the Observatory please complete the survey here
By Blank map of Europe (with disputed regions).svg: maix¿?derivative work: Alphathon - This file was derived from: Blank map of Europe (with disputed regions).svg:, CC BY-SA 3.0,